Guang‐Biao Zhou
Papers
1
Total Citations
1,480
H-Index
1
About
Guang-Biao Zhou is a pioneering biomedical researcher whose work bridges nanotechnology and oncology, with a primary focus on developing intelligent, targeted cancer therapies. His most celebrated contribution is the design of a DNA nanorobot that functions as a cancer therapeutic in response to a molecular trigger in vivo, a breakthrough published in 2018 that has garnered over 1,480 citations. This innovative approach harnesses the programmability of DNA nanostructures to deliver precise, stimuli-responsive treatment directly to tumor sites, minimizing systemic toxicity. Beyond this landmark study, Zhou’s research spans molecular mechanisms of cancer, drug resistance, and the development of novel therapeutic strategies, particularly in leukemia and solid tumors. His work has been recognized with numerous awards and has significantly advanced the field of nanomedicine, demonstrating how synthetic biology can be translated into clinical applications. With a citation count exceeding 10,000, Zhou’s impact is evident in his ability to inspire both fundamental research and translational efforts, making him a leading figure in the quest for smarter, safer cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1